Categories: HealthcareNews

PetMed Express, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

DELRAY BEACH, Fla., Aug. 21, 2024 (GLOBE NEWSWIRE) — PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS), will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference, to be held September 4-6, 2024 in New York.

Sandra Campos, CEO and President, will hold a fireside chat on September 6, 2024 at 7:45 a.m. (Eastern Time). A live audio webcast of the fireside chat will be available on the “Events & Presentations” section of PetMed’s investor relations website at https://investors.petmeds.com. After the event, a replay of the fireside chat will be archived and available on this same website for approximately 90 days.

About PetMed Express, Inc.

Founded in 1996, PetMeds is a leader in the digital pet pharmacy industry. As a national online retailer, PetMeds.com and PetCareRx.com are top choices for delivering preventive and chronic symptom prescriptions and OTC medications and products through their thousands of veterinary partners and a loyal customer base. Leveraging telehealth and insurance partnerships, they offer unparalleled value and convenience to pet parents at every stage of their pets’ lives, whether dogs, cats, or horses. PetMeds and PetCareRx provide a comprehensive range of medications, food products, and essential supplies through their websites, www.PetMeds.com and www.PetCareRx.com.

Investor Contact:
ICR, LLC
John Mills
(646) 277-1254
Reed Anderson
(646) 277-1260
investor@petmeds.com

Staff

Recent Posts

GI Innovation and GI Biome Advance to the Semi-finals of XPRIZE Healthspan with Anti-Aging Potential of GI-102 and GIB-7 Combination Therapy

GI Innovation and GI Biome have been selected as a Top 40 semi-finalist in the XPRIZE Healthspan competition among…

3 hours ago

Tyra Biosciences to Participate at Upcoming Investor Conferences

CARLSBAD, Calif., May 12, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology…

9 hours ago

Olio Raises $11M Series B Funding to Expand Product Innovation and Market Reach

Investment led by Fulcrum Equity Partners to accelerate Olio's mission of transforming care coordination. INDIANAPOLIS,…

9 hours ago

ZAC recognized as Trailblazer in Artificial Intelligence (AI) with innovative breakthroughs in Explainable AI (XAI)

POTOMAC, Md., May 12, 2025 /PRNewswire/ -- Z Advanced Computing, Inc. (ZAC), the pioneer Cognitive…

9 hours ago

Aranscia Acquires Spesana

Electronic Health Systems Pioneer Carla Balch Joins Aranscia's Executive Leadership Team HOUSTON, May 12, 2025…

15 hours ago